|
|
|
|
Direct Cost |
Indirect Cost |
|
1P30AI161943-01 |
Texas Developmental Center for AIDS Research |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$1,022,015 |
$276,811 |
$1,298,826 |
1R01AI153326-01A1 |
Innate DC Govern TH Polarization through the Novel Regulator AIMp1 |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$354,497 |
$212,698 |
$567,195 |
1R01AI158683-01A1 |
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$250,000 |
$150,000 |
$400,000 |
1R03AI151609-01A1 |
Determining the vector ecology and epidemiology of tick-borne spotted fever group Rickettsia in a large urban setting of Houston, TX. |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$50,000 |
$30,250 |
$80,250 |
1R21AI154342-01A1 |
Investigating parasitism-induced immune dysregulation and susceptibility to acute rheumatic fever in children |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$152,286 |
$69,561 |
$221,847 |
1R21AI156583-01 |
Novel Primary Immunodeficiency Disease Due to IL27RA Deficiency |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$150,000 |
$90,750 |
$240,750 |
1R21AI159323-01 |
Novel small-molecule inhibitors of SARS-CoV-2 protease |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$275,000 |
$165,000 |
$440,000 |
1R21AI163439-01 |
Small molecule inhibitors of HBx that decrease hepatitis B virus replication |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$150,000 |
$90,000 |
$240,000 |
1R34AI157948-01 |
Safety and Tolerability of Shrimp Oral Immunotherapy in Shrimp Allergic Subjects |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$195,170 |
$117,462 |
$312,632 |
1U19AI157981-01 |
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$1,507,323 |
$882,794 |
$2,390,117 |
272201300015I-P00002-759301900132-1 |
Vaccine and Treatment Evaluation Units: Administrative Support |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
|
|
$107,037 |
272201300015I-P00008-27200007-1 |
VTEU: Phase II Influenza Vaccine Trial |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
|
|
$87,205 |
2U19AI116497-06 |
Human Biomimetics for Mucosal Infections |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$1,083,973 |
$534,293 |
$1,618,266 |
3R01AI135803-04S1 |
IMPACC-MEDVAMC |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$204,996 |
$122,998 |
$327,994 |
3U19AI144297-03S1 |
Integrated Genomics of Mucosal Infections |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$394,628 |
$105,371 |
$499,999 |
3UM1AI148575-02S1 |
Vaccine and Treatment Evaluation Units (VTEU): CoVPN 5002: SARS-CoV-2 Prevalence Study |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$1,097,662 |
$658,597 |
$1,756,259 |
3UM1AI148575-02S2 |
Vaccine and Treatment Evaluation Units (VTEU) |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$262,349 |
$157,409 |
$419,758 |
3UM1AI148575-02S3 |
Vaccine and Treatment Evaluation Units (VTEU) |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$1,737,893 |
$435,186 |
$2,173,079 |
3UM1AI148575-02S4 |
Vaccine and Treatment Evaluation Units (VTEU) |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$1,634,250 |
$980,550 |
$2,614,800 |
3UM1AI148575-02S5 |
Vaccine and Treatment Evaluation Units (VTEU) |
BAYLOR COLLEGE OF MEDICINE |
NIAID |
$618,144 |
$370,886 |
$989,030 |